Category: 23andMe Research

Using Genetics and Family History for Health

For decades, a patient’s family health history has been a keystone to any wellness plan. A simple record of medical conditions your siblings, your parents, aunts, uncles and grandparents struggled with can help you and your doctor know what to watch for to keep you healthy. Like family health histories, ...

Read more

Novel Genetic Findings for Myeloproliferative Neoplasms

Dave Hinds is a Principal Scientist in Statistical Genetics.  23andMe is passionate about research on a group of rare blood disorders called myeloproliferative neoplasms, or MPNs. Physicians who study these disorders consider them to be blood cancers, though individual prognoses can vary widely — some people ...

Read more

The Genetics of Nearsightedness, Stretch Marks, and Motion Sickness

Amy Kiefer is a Survey Research Manager at 23andMe. She joined the company in 2008. What do nearsightedness, stretch marks, and motion sickness have to do with each other? They don’t appear to be genetically related — at least not according to our in-house statistical geneticists — but all of them are ...

Read more

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research ...

Read more

Cilantro Love and Hate: Is it a Genetic Trait?

We’re blogging about the various research projects and discoveries 23andMe scientists are presenting in November at the annual American Society of Human Genetics meeting. This is the first in our series of posts. Check back for more as the meeting gets closer! Hated, vile, foul herb; One mere leaf ...

Read more

Back-to-School: The Genetics of Learning from Your Mistakes

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Fighting Rare Blood Cancers

Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of enrolling 1,000 patients and are encouraged by what we’ve already learned. We’re also humbled that another star in the ...

Read more

23andMe’s Parkinson’s Research Featured on NPR

Our Parkinson’s research community got some welcome attention from NPR on Monday just as we are on the cusp of reaching our goal of enrolling 10,000 patients. The piece featured Emily Drabant, PhD, 23andMe’s research manager for our Parkinson’s community, and focused on our model of engaging patients as ...

Read more

Advocates for Women with Breast Cancer

In any big fight it helps to have someone in your corner and when it comes to breast cancer you want someone like Elyse Spatz Caplan and the people at Living Beyond Breast Cancer. Elyse, who herself was diagnosed and treated for breast cancer in 1991, oversees educational programming for Living Beyond ...

Read more

Incorporating Technology and DNA Testing into Clinical Trials

Many expensive clinical trials fail because the therapy causes harmful side effects in some or all participants or the drug isn’t effective across the board. Genetics may explain differences in response, but as of today DNA testing isn’t a standard part of clinical trials. Integrating genetic testing into ...

Read more

Return to top